BACKGROUND AND AIMS:The advent of highly effective hepatitis C (HCV) treatments has questioned the need for a vaccine to control HCV amongst people who inject drugs (PWID). However. high treatment costs and ongoing reinfection risk suggest it could still play a role. We compared the impact of HCV vaccination amongst PWID against providing HCV treatment. https://www.ngetikin.com/quick-sale-Korpskaft-Hultafors-great-choice/